Medical Excellence Capital
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B
Geographical Focus
United States
Industries Focus
- Healthcare
- Artificial Intelligence
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Machine Learning
- Biotechnology
- Synthetic Biology
- Regenerative Medicine
- Immunology
- Drug Discovery
- Cell Therapy
- Gene Therapy
- Drug Resistance
Investment Size:
100,000 to 5,000,000 USD
Investor Details Founded: 2020
An early-stage life science venture firm investing in disruptive technologies in precision health.
The firm focuses on areas such as cell therapy, gene therapy, artificial intelligence and machine learning applied to drug discovery, synthetic biology, and regenerative medicine.
Leveraging a network of over 1,200 physician-scientists across 33 major academic medical centers and research institutions in the U.S., the firm aims to accelerate the development of breakthrough technologies in the life sciences sector.
Requirements
- Innovative technologies in precision health
- Strong scientific and clinical evidence
- Experienced management teams
- Potential for significant impact on patient outcomes
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Portfolio Companies
- Ladder Bio Inc.
- GC Tx
- ProJenX Inc.
- Truvian Sciences
- Pleno
Mentioned In
Claim this Investor
Are you an official representative of Medical Excellence Capital?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim